Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
BNBNB Plus Corp. logo

BNB Plus Corp. (BNBX)

NASDAQ Global Market · Currency in USD
$0.16 ▲ +0.00 (+0.00%)
At close: Jul 13, 4:00 PM ET. Market closed.
$0.13 ▼ -0.03 (-18.04%)
After hours: Jul 13, 7:58 PM ET

Summary

Previous Close
$0.16
Open
$0.16
Day's Range
$0.15 – $0.19
52 Week Range
$0.11 – $7.15
Volume
4,589,063
Avg. Volume
887,952
Market Cap
$1.17M
Beta (5Y Monthly)
0.55
PE Ratio (TTM)
--
EPS (TTM)
-$3.54
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: BNB Plus Corp.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
26
CEO
Clay D. Shorrock
Website
bnbx.io

BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a biotechnology firm dedicated to pioneering and commercializing technologies for the synthesis and identification of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company's operations are divided into three distinct business segments. Its Therapeutic DNA Production Services division specializes in the enzymatic manufacturing of synthetic DNA, used in the creation of nucleic acid-based treatments, and also develops and markets its proprietary RNA Polymerase (RNAP) for mRNA therapeutic production.

Earnings

DateEst.Actual
May 15, 2026–-$0.68
Feb 12, 2026–-$2.08
Dec 22, 2025-$22.50-$3.17Beat
Aug 14, 2025-$37.50$34.00Beat
May 15, 2025-$0.45-$2.30Miss
Feb 13, 2025-$2.44-$4.20Miss

Get free alerts on BNBX and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.